Cargando…
Benchmarking of Scale-X Bioreactor System in Lentiviral and Adenoviral Vector Production
We have previously produced viral vectors (lentiviral vector, adenoviral vector, and adeno-associated viral vector) in small and in commercial scale in adherent cells using Pall fixed-bed iCELLis(®) bioreactor. Recently, a company called Univercells has launched a new fixed-bed bioreactor with the s...
Autores principales: | Leinonen, Hanna M., Lepola, Saana, Lipponen, Eevi M., Heikura, Tommi, Koponen, Tiina, Parker, Nigel, Ylä-Herttuala, Seppo, Lesch, Hanna P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Mary Ann Liebert, Inc., publishers
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7087403/ https://www.ncbi.nlm.nih.gov/pubmed/32075423 http://dx.doi.org/10.1089/hum.2019.247 |
Ejemplares similares
-
Development of Large-Scale Downstream Processing for Lentiviral Vectors
por: Valkama, Anniina J., et al.
Publicado: (2020) -
Optimization of lentiviral vector production for scale-up in fixed-bed bioreactor
por: Valkama, A J, et al.
Publicado: (2018) -
Preclinical Proof-of-Concept, Analytical Development, and Commercial Scale Production of Lentiviral Vector in Adherent Cells
por: Leinonen, Hanna M., et al.
Publicado: (2019) -
Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
por: Eriksson, Reetta A. E., et al.
Publicado: (2022) -
Corrigendum: Optimized riboswitch-regulated AAV vector for VEGF-B gene therapy
por: Eriksson, Reetta A. E., et al.
Publicado: (2023)